Christophe Douat
Chairman
drug administration
Nanobiotix
France
Biography
Christophe Douat is currently Chairman of Medincell, a pharmaceutical company that specializes in drug administration technologies, and President of Great North, dedicated to advise companies with disruptive technology. Christophe was a member of the Supervisory Board of Nanobiotix from 2006 to 2009 when he was lead investor, and was appointed again member of the Board in 2011. Christophe joined the venture capital company Matignon Technologies in 2001, where he has invested in a broad range of companies and founded Matignon Technologies II, one of Europe’s largest funds specialized in Medtech. Christophe is also an alumni of the Boston Consulting Group. He graduated from Ecole des Mines de Paris and holds an MS (US) and an MBA (Canada).
Research Interest
drug administration technologies
